ABCL (STOCKS)
AbCellera Biologics Inc. Common Shares
$3.090000
-0.070000 (-2.22%)
Prev close: $3.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Carl Lars G. Hansen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $924.95M
- Employees
- 596
- P/E (TTM)
- -5.48
- P/B (TTM)
- 0.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
9
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.19 | $-0.17 | -0.0179 | -10.40% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.17 | +0.0493 | +29.12% |
|
Mar 2025 (Q1)
|
$-0.15 | $-0.14 | -0.0052 | -3.59% |
|
Dec 2024 (Q4)
|
$-0.11 | $-0.16 | +0.0468 | +29.85% |
Financial Statements
| Assets | $1.36B |
| Current Assets | $695.14M |
| Cash | $495.67M |
| Accounts Receivable | $71.25M |
| Other Current Assets | $128.22M |
| Noncurrent Assets | $660.85M |
| Intangible Assets | $39.32M |
| Other Non-current Assets | $621.53M |
| Liabilities | $391.95M |
| Current Liabilities | $68.80M |
| Wages | $7.23M |
| Other Current Liabilities | $61.57M |
| Noncurrent Liabilities | $323.15M |
| Equity | $964.04M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $964.04M |
| Liabilities And Equity | $1.36B |